BIO-key International (NASDAQ:BKYI) Issues Earnings Results, Beats Estimates By $0.26 EPS

BIO-key International (NASDAQ:BKYI) posted its earnings results on Thursday. The technology company reported ($0.56) earnings per share for the quarter, beating the consensus estimate of ($0.82) by $0.26, FiscalAI reports. BIO-key International had a negative net margin of 50.01% and a negative return on equity of 64.12%. The firm had revenue of $1.92 million during the quarter, compared to analyst estimates of $1.80 million.

BIO-key International Price Performance

Shares of NASDAQ BKYI traded down $0.59 during midday trading on Friday, hitting $3.18. The company’s stock had a trading volume of 97,190 shares, compared to its average volume of 207,922. The firm has a market capitalization of $3.47 million, a price-to-earnings ratio of -0.77 and a beta of 0.44. The business’s fifty day simple moving average is $4.34 and its two-hundred day simple moving average is $5.24. BIO-key International has a 1 year low of $2.96 and a 1 year high of $19.70.

Institutional Investors Weigh In On BIO-key International

An institutional investor recently raised its stake in BIO-key International stock. Geode Capital Management LLC raised its holdings in BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the period. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. 26.51% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of BIO-key International in a research report on Friday, July 17th. Zacks Research upgraded shares of BIO-key International to a “hold” rating in a research report on Thursday, August 6th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Reduce”.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.